Posts Tagged ‘ Endo Pharmaceuticals ’

LEGAL THOUGHTS ON THE AMS TRANSVAGINAL MESH SETTLEMENT

May 22nd, 2014 | By
LEGAL THOUGHTS ON THE AMS TRANSVAGINAL MESH SETTLEMENT

SPONSORED CONTENT By Dan C. Bolton, Of Counsel, Keller, Fishback & Jackson LLP                 Recently, Endo Pharmaceuticals announced that it had reached a settlement in principle with four law firms representing plaintiffs in the transvaginal mesh litigation pending before Judge Goodwin in federal district court in West Virginia (MDL 2325).  The Press Release issued by
[continue reading...]



Hundreds of Utah Women File Lawsuits Alleging Complications for Pelvic Implants

Jul 8th, 2012 | By
Hundreds of Utah Women File Lawsuits Alleging Complications for Pelvic Implants

~Salt Lake Tribune, July 8, 2012 “Lee” had a pelvic mesh sling implanted six years ago to treat incontinence, which was an inconvenience. But after two surgeries and continuing health complications, Lee and about 50 other Utah women have filed lawsuits alleging they are suffering “severe and permanent  bodily injuries” from the pelvic mesh devices
[continue reading...]



Plaintiffs Want Mesh Lawsuits Centralized

Dec 22nd, 2011 | By
Plaintiffs Want Mesh Lawsuits Centralized

DECEMBER 22, 2011 – The Athens Georgia law firm of Blasingame, Burch, Garrard & Ashley, P.C. has filed a motion to have various plaintiffs from around the country centralize their defective transvaginal surgical mesh litigation in one federal court – the Southern District of West Virginia. Share this:



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.